<!DOCTYPE html>

<!--
  Created : 1/19/2012 2:43:29 PM
  Author : Tom Coleman
  Copyright : 2011-2011
  By : University of Missippi Medical Center
-->

<html>
<head>
<title> Model </title>
<link rel='stylesheet' type='text/css' href='../../Style.CSS'>
</head>

<body>

<img src='../../SmallTitle.PNG'>
<img src='../XMLLightBlue.PNG'>
<a href='Docs_BloodVolume.html'><img src='../../Back.PNG'></a>
<p>
QHP 2008 / BloodVolume.DOCS<br>
<br>
Created : 27-Mar-09<br>
Last Modified : 27-Mar-09<br>
Author : Tom Coleman<br>
Copyright : 2009<br>
<br>
&lt;structurename&gt; [EPO]Delay &lt;/structurename&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; [EPO]Delay.Derv &lt;/name&gt;<br>
&lt;topic&gt; Derv - Definition &lt;/topic&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; [EPO]Delay.Effect &lt;/name&gt;<br>
&lt;topic&gt; EPO Delay - Overview &lt;/topic&gt;<br>
&lt;topic&gt; EPO - Physical Units &lt;/topic&gt;<br>
&lt;topic&gt; EPO - Concentration Units &lt;/topic&gt;<br>
&lt;seealso&gt; [EPO]Delay.SteadyState &lt;/seealso&gt;<br>
&lt;seealso&gt; [EPO]Delay.K &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; [EPO]Delay.K &lt;/name&gt;<br>
&lt;topic&gt; K - Overview &lt;/topic&gt;<br>
&lt;topic&gt; EPO - Physical Units &lt;/topic&gt;<br>
&lt;topic&gt; EPO - Concentration Units &lt;/topic&gt;<br>
&lt;seealso&gt; [EPO]Delay.Tau &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; [EPO]Delay.SteadyState &lt;/name&gt;<br>
&lt;topic&gt; Steady State - Overview &lt;/topic&gt;<br>
&lt;topic&gt; EPO - Physical Units &lt;/topic&gt;<br>
&lt;topic&gt; EPO - Concentration Units &lt;/topic&gt;<br>
&lt;seealso&gt; EPOPool.Log10Conc &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; [EPO]Delay.Tau &lt;/name&gt;<br>
&lt;topic&gt; Tau - Overview &lt;/topic&gt;<br>
&lt;topic&gt; EPO - Physical Units &lt;/topic&gt;<br>
&lt;topic&gt; EPO - Concentration Units &lt;/topic&gt;<br>
&lt;/vardoc&gt;<br>
<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; EPO Delay - Overview &lt;/name&gt;<br>
&lt;label&gt; Overview &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
EPO Delay<br>
Erythropoietin (EPO) is a glycoprotein <br>
which increases red blood cell (RBC) <br>
production in response to decreases in <br>
tissue oxygenation. Although increased secretion <br>
of erythropoietin occurs within minutes of a <br>
decrease in tissue oxygenation ,it takes several <br>
days before there is an increase in the red blood <br>
cell concentration - this is the EPO delay.<br>
EPO increases erythrocyte production by retarding <br>
DNA breakdown and preventing apoptosis in erythroid <br>
progenitor cells.<br>
<br>
Erslev, A.J. Erythropoietin. <br>
Leukemia Research Volume 14, No. 8: 683-688, 1990<br>
<br>
Relationship between blood loss, EPO concentration <br>
and effect on reticulocyte concentration<br>
Miller Me, Cronkite EP, Garcia JF<br>
 <br>
Plasma levels of immunoreactive erythropoietin<br>
after acute blood loss in man.<br>
Brit J Haematology 52: 545-549, 1982<br>
<br>
Effect of EPO infusion on reticulocyte concentration.<br>
Escbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW<br>
correction of the anemia of end-stage renal disease <br>
with recombinant human erythropoietin<br>
New Eng J Med 316:73-78, 1987<br>
<br>
Winearls CG, Oliver DO, Pippard MJ, Reid C,<br>
Downing MR, Cotes PM. Effect of human erythropoietin<br>
derived from recombinant DNA on the anaemia of patients <br>
maintained by chronic haemodialysis.<br>
Lancet 2:1175-1178, 1986<br>
<br>
Koury MJ, Bondurant MC.<br>
Erythropoietin retards DNA breakdown and prevents<br>
programmed death in erythroid progenitor cells.<br>
Science Vol 248: 378-381, 1990<br>
<br>
K is the rate constant<br>
and is 1/Tau, (Tau = the time constant). <br>
A steady state is achieved when red blood cell <br>
volume reaches constant levels. <br>
<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; EPO - Physical Units &lt;/name&gt;<br>
&lt;label&gt; Physical Units &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
[Plasma] mU/mL<br>
Flux  U/min<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; EPO - Concentration Units &lt;/name&gt;<br>
&lt;label&gt; Concentration Units &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Typical [EPO] is 20mU/mL at a secretion rate of 0.67U/min<br>
Tau = 3days. K =1/Tau  <br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; K - Overview &lt;/name&gt;<br>
&lt;label&gt; Overview &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
K is the rate constant<br>
and is 1/Tau, (Tau = the time constant). <br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Steady State - Overview &lt;/name&gt;<br>
&lt;label&gt; Overview &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
A steady state is achieved when red blood cell <br>
volume reaches constant levels. <br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Tau - Overview &lt;/name&gt;<br>
&lt;label&gt; Overview &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
K is the rate constant<br>
and is 1/Tau, (Tau = the time constant). <br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Derv - Defintion &lt;/name&gt; <br>
&lt;label&gt; Defintion &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
 <br>
End

<p><img src='../../Footer.PNG'>

</body>
</html>
